Guardant Health (GH) Revenue (2017 - 2026)

Guardant Health has reported Revenue for 10 years, with the latest figure at $335.0 million in Q2 2026.

• Quarterly Revenue rose 44.33% year-over-year to $335.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.2 billion (up 42.74% YoY) and the FY2025 annual result came in at $982.0 million, up 32.88% from the prior year.
• Revenue improved to $335.0 million in Q2 2026 per GH's latest filing, from $301.7 million in the prior quarter.
• Over five years, Revenue peaked at $335.0 million in Q2 2026 and troughed at $96.1 million in Q1 2022.
• A 5-year average of $187.3 million and a median of $172.9 million in 2024 frame the typical range for Revenue.
• The sharpest annual moves came in 2022 and 2026: Revenue rose 17.37% in 2022, then jumped 48.26% in 2026.
• Over 5 years, Revenue stood at $126.9 million in 2022, then climbed by 22.19% to $155.1 million in 2023, then jumped by 30.16% to $201.8 million in 2024, then soared by 39.37% to $281.3 million in 2025, then gained by 19.1% to $335.0 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $335.0 million, $301.7 million, and $281.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.